<?xml version="1.0"?>
<Articles JournalTitle="International Journal of Hematology-Oncology and Stem Cell Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>1</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2004</Year>
        <Month>03</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Chronic Graft versus Host Disease after Allogeneic Bone Marrow Transplantation; An Analysis of Incidence and Risk Factors.</title>
    <FirstPage>16</FirstPage>
    <LastPage>19</LastPage>
    <AuthorList>
      <Author>
        <FirstName>A</FirstName>
        <LastName>Ghavamzadeh</LastName>
        <affiliation locale="en_US">Hematology- Oncology and BMT Research Center, Shariati Hospital, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>K</FirstName>
        <LastName>Alimoghaddam</LastName>
        <affiliation locale="en_US">Hematology- Oncology and BMT Research Center, Shariati Hospital, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>B</FirstName>
        <LastName>Bahar</LastName>
        <affiliation locale="en_US">Hematology- Oncology and BMT Research Center, Shariati Hospital, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>F</FirstName>
        <LastName>Foroughi</LastName>
        <affiliation locale="en_US">Hematology- Oncology and BMT Research Center, Shariati Hospital, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Chronic graft versus host disease (cGVHD) is one of the most serious potential complications of allogeneic bone marrow transplantation.
 Study design and method: We analyzed the incidence of cGVHD and its associated risk factors in a group of 161 Iranian recipients of HLA-identical sibling transplants, with at least 90 days post-transplantation survival. In the majority of cases (n=73), cGVHD occurred in the first year after the transplant (median 273 days). The actual probability of cGVHD within 1 year was 45.3&#xB1;7% (CI 95%). 
Results: In a univariate analysis, the most important risk factor was the type of transplant. Peripheral blood stem cell transplants (PBSCT) showed a significant increase in cGVHD compared with bone marrow transplants (BMT) (RR=2.34, p&lt;0.001). In addition, male recipients were at a greater risk than female recipients (RR=2.08, p=0.004). Other risk factors were the presence of prior acute GVHD (RR=2.37, p=0.04) and the previous acute GVHD grade (p=0.03); The probabilities of cGV D in patients with grade 0, &#x399;, &#x399;&#x406;, &#x399;&#x399;&#x399;, &#x399;V acute GVHD were 24%, 44.7%, 42.6%, 56.8%, 64.3%, respectively. 
Conclusion: In a multivariate analysis, the only independent predictive factors for the development of cGVHD were the type of transplant (PBSC&gt;BM, p&lt;0.001) and male recipient (p=0.005). The survival rate was 88.8% and there was no significant difference in the probability of survival between BPSCT vs BMT (93.8% vs 86.6%, p=0.5).</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/163</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/163/156</pdf_url>
  </Article>
</Articles>
